Pasithea Therapeutics Corp. (KTTA)
0.5801
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.5801
0.00 (0.00%)
After-Hours: 18:02
Pasithea Therapeutics Market Cap : 19.38M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 19.39M |
| September 02, 2026 | 19.39M |
| September 01, 2026 | 18.81M |
| August 31, 2026 | 19.18M |
| August 28, 2026 | 18.71M |
| August 27, 2026 | 18.53M |
| August 26, 2026 | 19.05M |
| August 25, 2026 | 18.71M |
| August 24, 2026 | 16.87M |
| August 21, 2026 | 18.02M |
| August 20, 2026 | 15.70M |
| August 19, 2026 | 16.37M |
| August 18, 2026 | 16.63M |
| August 17, 2026 | 15.97M |
| August 14, 2026 | 16.06M |
| August 13, 2026 | 15.97M |
| August 12, 2026 | 16.37M |
| August 11, 2026 | 15.94M |
| August 10, 2026 | 11.82M |
| August 07, 2026 | 12.64M |
| August 06, 2026 | 11.06M |
| August 05, 2026 | 11.22M |
| August 04, 2026 | 11.47M |
| August 03, 2026 | 11.14M |
| July 31, 2026 | 11.47M |
| Date | Value |
|---|---|
| July 30, 2026 | 11.07M |
| July 29, 2026 | 11.22M |
| July 28, 2026 | 11.22M |
| July 27, 2026 | 11.22M |
| July 24, 2026 | 11.35M |
| July 23, 2026 | 11.98M |
| July 22, 2026 | 11.47M |
| July 21, 2026 | 11.34M |
| July 20, 2026 | 11.80M |
| July 17, 2026 | 11.22M |
| July 16, 2026 | 11.40M |
| July 15, 2026 | 11.92M |
| July 14, 2026 | 12.02M |
| July 13, 2026 | 12.22M |
| July 10, 2026 | 12.28M |
| July 09, 2026 | 12.47M |
| July 08, 2026 | 12.76M |
| July 07, 2026 | 12.96M |
| July 06, 2026 | 12.97M |
| July 02, 2026 | 13.71M |
| July 01, 2026 | 14.14M |
| June 30, 2026 | 12.85M |
| June 29, 2026 | 13.12M |
| June 26, 2026 | 13.55M |
| June 25, 2026 | 13.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.821B |
| Alnylam Pharmaceuticals, Inc. | 35.59B |
| Anika Therapeutics, Inc. | 278.70M |
| Savara, Inc. | 1.102B |
| Vericel Corp. | 2.057B |
Market Cap Related Metrics
| Price to Book Value | 0.3889 |
| Price | 0.5801 |
| Earnings Yield | -272.3% |